NULISASEQ Trademark

Trademark Overview

On Monday, December 5, 2022, a trademark application was filed for NULISASEQ with the United States Patent and Trademark Office. The USPTO has given the NULISASEQ trademark a serial number of 97704154. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, July 29, 2025. This trademark is owned by Alamar Biosciences, Inc.. The NULISASEQ trademark is filed in the Chemical Products category with the following description:

immunoassay reagents for scientific research use
nulisaseq

General Information

Serial Number97704154
Word MarkNULISASEQ
Filing DateMonday, December 5, 2022
Status641 - NON-FINAL ACTION - MAILED
Status DateTuesday, July 29, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and Servicesimmunoassay reagents for scientific research use

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateMonday, October 16, 2023
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAlamar Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFremont, CA 94538

Trademark Events

Event DateEvent Description
Thursday, December 8, 2022NEW APPLICATION ENTERED
Thursday, December 8, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 29, 2023ASSIGNED TO EXAMINER
Friday, September 1, 2023NON-FINAL ACTION WRITTEN
Friday, September 1, 2023NON-FINAL ACTION E-MAILED
Friday, September 1, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 16, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 16, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 16, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 9, 2023SUSPENSION LETTER WRITTEN
Thursday, November 9, 2023LETTER OF SUSPENSION E-MAILED
Thursday, November 9, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, May 10, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, January 24, 2025REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, July 25, 2025SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, July 29, 2025NON-FINAL ACTION WRITTEN
Tuesday, July 29, 2025NON-FINAL ACTION E-MAILED
Tuesday, July 29, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 23, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 23, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 23, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 28, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, October 28, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, December 30, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 30, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 30, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

nulisaseq research scientific reagents immunoassay